A detailed history of Cullinan Associates Inc transactions in Baxter International Inc stock. As of the latest transaction made, Cullinan Associates Inc holds 20,200 shares of BAX stock, worth $672,862. This represents 0.04% of its overall portfolio holdings.

Number of Shares
20,200
Previous 20,200 -0.0%
Holding current value
$672,862
Previous $675,000 13.48%
% of portfolio
0.04%
Previous 0.04%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$32.87 - $43.55 $6,573 - $8,710
-200 Reduced 0.98%
20,200 $675,000
Q4 2022

Jan 11, 2023

BUY
$49.7 - $57.71 $124,250 - $144,275
2,500 Added 13.97%
20,400 $1.04 Million
Q3 2022

Oct 19, 2022

SELL
$53.86 - $66.8 $6,732 - $8,350
-125 Reduced 0.69%
17,900 $964,000
Q1 2022

Apr 21, 2022

SELL
$76.85 - $89.45 $3,842 - $4,472
-50 Reduced 0.28%
18,025 $1.4 Million
Q2 2021

Jul 07, 2021

BUY
$80.5 - $88.01 $120,750 - $132,015
1,500 Added 9.05%
18,075 $1.46 Million
Q1 2021

Apr 20, 2021

BUY
$76.38 - $86.03 $133,665 - $150,552
1,750 Added 11.8%
16,575 $1.4 Million
Q4 2020

Jan 14, 2021

BUY
$75.39 - $82.36 $1.12 Million - $1.22 Million
14,825 New
14,825 $1.19 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Cullinan Associates Inc Portfolio

Follow Cullinan Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullinan Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cullinan Associates Inc with notifications on news.